search
Back to results

Protocolized Post-Extubation Respiratory Support Study (PROPER)

Primary Purpose

Mechanical Ventilation Complication, Acute Respiratory Failure, Intubation Complication

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Protocolized post-extubation respiratory support
Usual Care
Sponsored by
Vanderbilt University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Mechanical Ventilation Complication

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patient is located in a participating unit
  2. Patient undergoing extubation from mechanical ventilation
  3. Patient has been receiving mechanical ventilation for at least 12 hours
  4. Age ≥ 18 years old

Exclusion Criteria:

  1. Patient is receiving ventilation via a tracheostomy
  2. Patient is being extubated to comfort measures or has "Do Not Reintubate" order in place at the time of extubation
  3. Patient has required reintubation after a prior attempt at extubation during this hospitalization
  4. Unplanned or self-extubation, where immediate reintubation is deemed necessary by the clinical team

Sites / Locations

  • Vanderbilt University Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Protocolized Post-extubation Respiratory Support

Usual Care

Arm Description

Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning

Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.

Outcomes

Primary Outcome Measures

Reintubation
Any placement of an endotracheal tube for any indication within 96 hours of extubation, censored at the first of hospital discharge or 96 hours after extubation

Secondary Outcome Measures

All-cause in-hospital death
All cause mortality, censored at the first of hospital discharge or 28 days after extubation
ICU-free days
number of days alive from final ICU transfer until study day 28
Ventilator-free days
number of days alive from final invasive mechanical ventilation until study day 28
Time to reintubation
Time from extubation to reintubation
Indication for re-intubation
Proportion of patients in each group with respiratory vs non-respiratory indications for reintubation
Laryngeal edema requiring reintubation
Proportion of patients in each group with laryngeal edema as the indication for reintubation
Delirium
As defined by CAM-ICU score and reported by bedside nurse
Agitation
As defined by RAS score and reported by bedside nurse
Lowest S/F ratio
Lowest ratio of O2 saturation to concentration inhaled oxygen (FIO2)
Highest respiratory rate
Highest respiratory rate
Use of HFNC or NIV beyond 24 hours post-extubation
Use of non-invasive ventilation or high flow nasal cannula beyond 24 hours post-extubation

Full Information

First Posted
September 15, 2017
Last Updated
February 21, 2020
Sponsor
Vanderbilt University Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT03288311
Brief Title
Protocolized Post-Extubation Respiratory Support Study
Acronym
PROPER
Official Title
Protocolized Post-Extubation Respiratory Support (PROPER) Study
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
October 1, 2017 (Actual)
Primary Completion Date
March 31, 2019 (Actual)
Study Completion Date
April 28, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Vanderbilt University Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Invasive mechanical ventilation is common in the medical intensive care unit, and the period of time following extubation remains high risk as 11 to 15% of patients require reintubation after their first extubation. Reintubation is associated with increased rates of nosocomial infection and is an independent predictor of mortality. Non-invasive ventilation and high flow nasal cannula are the only therapies that have been shown to reduce the rate of reintubation. Recent clinical trials suggest that all patients might benefit from some form of post-extubation respiratory support, but use of these therapies in usual care remains low. PROPER is a cluster-randomized, multiple-crossover trial comparing a respiratory therapist driven protocol to provide post-extubation respiratory support to all patients, compared to usual care. The trial will enroll patients undergoing extubation in the Medical ICU at Vanderbilt from October 2017 until March 2019. The primary outcome will be reintubation within 96 hours.
Detailed Description
PROPER is a prospective, pragmatic, cluster-randomized, multiple-crossover trial comparing a respiratory therapist driven protocol for post-extubation respiratory support to usual care. The primary outcome will be reintubation by 96 hours. All adults (age 18 or older) who receive at least 12 hours of mechanical ventilation and are extubated in the Vanderbilt Medical ICU will be enrolled in the trial. The ICU will be divided into 2 clusters, based on the geographic areas covered by the two respiratory therapist dedicated to that ICU. The study will occur in three month blocks. One cluster will be randomized to receive protocolized post-extubation respiratory support (as prescribed by a protocol and delivered by a respiratory therapist), while the other cluster receives usual care, which can include post-extubation respiratory support when requested by the clinical team. At the end of three months, the clusters will cross-over, such that each cluster will spend half of the study receiving protocolized post-extubation respiratory and half of the study receiving usual care. It is anticipated that approximately 630 patients will be enrolled from the medical ICU during the 18 month study period.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mechanical Ventilation Complication, Acute Respiratory Failure, Intubation Complication

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
751 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Protocolized Post-extubation Respiratory Support
Arm Type
Active Comparator
Arm Description
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Arm Title
Usual Care
Arm Type
Active Comparator
Arm Description
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
Intervention Type
Other
Intervention Name(s)
Protocolized post-extubation respiratory support
Intervention Description
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Intervention Type
Other
Intervention Name(s)
Usual Care
Intervention Description
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
Primary Outcome Measure Information:
Title
Reintubation
Description
Any placement of an endotracheal tube for any indication within 96 hours of extubation, censored at the first of hospital discharge or 96 hours after extubation
Time Frame
within 96 hours of extubation
Secondary Outcome Measure Information:
Title
All-cause in-hospital death
Description
All cause mortality, censored at the first of hospital discharge or 28 days after extubation
Time Frame
from extubation to discharge or 28 days post-extubation
Title
ICU-free days
Description
number of days alive from final ICU transfer until study day 28
Time Frame
from extubation to discharge or 28 days post-extubation
Title
Ventilator-free days
Description
number of days alive from final invasive mechanical ventilation until study day 28
Time Frame
from extubation to discharge or 28 days post-extubation
Title
Time to reintubation
Description
Time from extubation to reintubation
Time Frame
from extubation to discharge or 28 days post-extubation
Title
Indication for re-intubation
Description
Proportion of patients in each group with respiratory vs non-respiratory indications for reintubation
Time Frame
within 96 hours of extubation
Title
Laryngeal edema requiring reintubation
Description
Proportion of patients in each group with laryngeal edema as the indication for reintubation
Time Frame
within 96 hours of extubation
Title
Delirium
Description
As defined by CAM-ICU score and reported by bedside nurse
Time Frame
within 96 hours of extubation
Title
Agitation
Description
As defined by RAS score and reported by bedside nurse
Time Frame
within 96 hours of extubation
Title
Lowest S/F ratio
Description
Lowest ratio of O2 saturation to concentration inhaled oxygen (FIO2)
Time Frame
between 0-6 hours, 6-12 hours, and 12-24 hours after extubation
Title
Highest respiratory rate
Description
Highest respiratory rate
Time Frame
between 0-6 hours, 6-12 hours, and 12-24 hours after extubation
Title
Use of HFNC or NIV beyond 24 hours post-extubation
Description
Use of non-invasive ventilation or high flow nasal cannula beyond 24 hours post-extubation
Time Frame
from extubation to 96 hours post-extubation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient is located in a participating unit Patient undergoing extubation from mechanical ventilation Patient has been receiving mechanical ventilation for at least 12 hours Age ≥ 18 years old Exclusion Criteria: Patient is receiving ventilation via a tracheostomy Patient is being extubated to comfort measures or has "Do Not Reintubate" order in place at the time of extubation Patient has required reintubation after a prior attempt at extubation during this hospitalization Unplanned or self-extubation, where immediate reintubation is deemed necessary by the clinical team
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Todd W Rice, MD, MSc
Organizational Affiliation
Vanderbilt University Medical Center
Official's Role
Study Chair
Facility Information:
Facility Name
Vanderbilt University Medical Center
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37212
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Time Frame
Data will be available following publication of the primary trial results
IPD Sharing Access Criteria
Data dictionary will be available upon requests. Requests for deidentified patient-level data will be reviewed by the trial steering committee. Sharing of deidentified data will require approval of proposed secondary analysis and a signed data use agreement.
Citations:
PubMed Identifier
33794131
Citation
Casey JD, Vaughan EM, Lloyd BD, Billas PA, Jackson KE, Hall EJ, Toporek AH, Buell KG, Brown RM, Richardson RK, Rooks JC, Buie RB, Wang L, Lindsell CJ, Ely EW, Self WH, Bernard GR, Rice TW, Semler MW. Protocolized Postextubation Respiratory Support to Prevent Reintubation: A Randomized Clinical Trial. Am J Respir Crit Care Med. 2021 Aug 1;204(3):294-302. doi: 10.1164/rccm.202009-3561OC.
Results Reference
derived
PubMed Identifier
31377713
Citation
Casey JD, Vaughan ER, Lloyd BD, Bilas PA, Hall EJ, Toporek AH, Buell KG, Brown RM, Richardson RK, Rooks JC, Wang L, Lindsell CJ, Ely EW, Self WH, Bernard GR, Rice TW, Semler MW; Pragmatic Critical Care Research Group. Protocolized Post-Extubation Respiratory Support to prevent reintubation: protocol and statistical analysis plan for a clinical trial. BMJ Open. 2019 Aug 2;9(8):e030476. doi: 10.1136/bmjopen-2019-030476.
Results Reference
derived

Learn more about this trial

Protocolized Post-Extubation Respiratory Support Study

We'll reach out to this number within 24 hrs